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Abstract
In an acute study, cholecystokinin octapeptide sulfate (CCK) in doses of 1, 10 or 100 micro-
grams/kg body weight was injected intraperitoneally into rats just prior to the dark cycle. Rats
were sacrificed two hours following the CCK injection. Norepinephrine levels were elevated in
the dorsal amygdala of rats injected with 10 micrograms of CCK as well as in the septum of rats
injected with 1 and 10 micrograms of CCK. The dopamine level in the septum of rats injected
with 1 microgram of CCK as well as the gamma-aminobutyric acid (GABA) level in the lateral
hypothalamus of rats injected with 10 micrograms of CCK were also elevated. In a chronic study,
CCK (1 microgram/kg body weight/h) was subcutaneously infused into rats with Alzet osmotic
minipump for seven consecutive days. The daily food consumption did not change during the 7
days of CCK infusion. The dopamine turnover in the striatum accelerated and the GABA level
increased. On the contrary, dopamine metabolism in the substantia nigra and locus coeruleus
decreased. Furthermore, the serotonin level in the substantia nigra decreased. Norepinephrine
levels decreased in the nucleus paraventricularis, the locus coeruleus and the substantia nigra. The
results suggest that peripherally administered CCK may act on the monoaminergic neurons and
GABAergic neurons in the brain.
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